About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

ATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1

NCT07528014·2 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Salma Health, Inc.

With

Center for Neurohealth, Inc

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Adults (≥18 years) of any gender identity presenting for care with a depressed mood.
Prescribed treatment with esketamine, conventional TMS, or SAINT as part of standard clinical care.
Able to provide informed consent and comply with all study requirements.

You may not be if

Any condition deemed by the investigator to preclude safe participation in study assessments.

The record

StatusRecruiting

PhaseNo phase

Taking part5,000

StartedMar 2026

UpdatedApr 14, 2026

Conditions

Where2

Salma Health
La Jolla, California, United States
Salma Health
Laguna Hills, California, United States

Clareo Health | ATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1